SEC Form 4 Summary ZYME

Zymeworks' Paul Andrew Moore Reports $651,000 Share Sale

Zymeworks Chief Scientific Officer Paul Andrew Moore sold 25,000 ZYME shares for $651,000 on November 13, 2026.

Transaction Value:
$651,000.00
Shares transacted:
25,000
Average price:
$26.04
Insider:

The Form 4 filing, an SEC report of an insider's share activity, was filed on November 16, 2026. It lists November 13 as the transaction date for Paul Andrew Moore, Zymeworks' chief scientific officer.

Transaction details

Transaction
Date of Earliest Transaction2026-11-13
Date of Latest Transaction2026-11-13
Buy/Sellsell
Transaction Count1
Shares Transacted25,000
Price$26.04
Total Transaction Value$651,000.00
Insider
Ticker SymbolZYME
CompanyZymeworks Inc.
Insider NameMoore Paul Andrew
Insider TitleChief Scientific Officer
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction33,756
Position Size Change42.55%
Filing
Filing Date2026-11-16
SEC LinkView filing

FAQ

What type of transaction is this?

This was a sale of ZYME shares, reported with SEC transaction code S. The transaction information also suggests a link to an exercise or conversion.

An exercise can mean using a stock option, a right to buy shares. A conversion turns another investment into shares.

What was the average price of the transaction?

The average sale price was $26.04 per share for the one reported transaction.

How did this transaction affect the insider's holdings?

Paul Andrew Moore sold 25,000 shares and reported 33,756 shares owned afterward. He sold 42.55% of the shares he owned before the sale.

What's the total transaction value?

The total reported transaction value was $651,000.00. That amount covers the single sale of 25,000 shares.

Are there any special circumstances around this transaction?

The sale may be linked to an exercise or conversion with the same share count. The transaction information identifies a match between a code M share acquisition and this code S sale in the same filing.

Details of the code M acquisition and the filing's footnotes are not available here. Matching share counts alone do not confirm matching dates, share types, or accounts. They also do not show that the shares acquired were the ones sold. The sale's purpose and whether it was required remain unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.